To determine whether a set of functional tests, clinical scales, patient-reported questionnaires, and specific biomarkers can be considered reliable outcome measures in patients with primary mitochondrial myopathy (PMM), we analyzed a cohort of Italian patients.
Montano, V., Gruosso, F., Carelli, V., Comi, G.P., Filosto, M., Lamperti, C., et al. (2020). Primary mitochondrial myopathy: Clinical features and outcome measures in 118 cases from Italy. NEUROLOGY. GENETICS, 6(6), 1-11 [10.1212/NXG.0000000000000519].
Primary mitochondrial myopathy: Clinical features and outcome measures in 118 cases from Italy
Carelli, Valerio;Valentino, Maria Lucia;
2020
Abstract
To determine whether a set of functional tests, clinical scales, patient-reported questionnaires, and specific biomarkers can be considered reliable outcome measures in patients with primary mitochondrial myopathy (PMM), we analyzed a cohort of Italian patients.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
e519.full.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
448.41 kB
Formato
Adobe PDF
|
448.41 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
